×
About 570 results

ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Research & Reviews  208 results

Pathology of Eosinophilic Pneumonia
http://emedicine.medscape.com/article/2078412-overview

Jan 5th, 2022 - Definition The definition of eosinophilic pneumonia depends on the clinical context. In pathology, eosinophilic pneumonia refers to a histologic pattern of diffuse pulmonary infiltrates that contain prominent numbers of eosinophils with or without...

Pathology of Eosinophilic Pneumonia
https://emedicine.medscape.com/article/2078412-print

Jan 5th, 2022 - The definition of eosinophilic pneumonia depends on the clinical context. In pathology, eosinophilic pneumonia refers to a histologic pattern of diffuse pulmonary infiltrates that contain prominent numbers of eosinophils with or without peripheral...

Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms.
https://doi.org/10.1016/S1473-3099(21)00423-0
The Lancet. Infectious Diseases; Chen TT, Zhou P et. al.

Dec 27th, 2021 - Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms.|2021|Chen TT,Zhou P,Nie L,Lei Y,Li D,|therapeutic use,diagnostic imaging,drug therapy,drug effects,pathogenicity,microbiology,

Total unilateral pulmonary collapse secondary to allergic bronchopulmonary aspergillosi...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709957
BMC Pulmonary Medicine; Benkalfate N, Dirou S et. al.

Dec 26th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is a bronchopulmonary disease caused by a complex hypersensitivity to Aspergillus and is usually associated with underlying respiratory diseases such as asthma or cystic fibrosis. Mucus plugging can l...

Nebulised liposomal-amphotericin-B as maintenance therapy in ABPA: a randomised, multic...
https://doi.org/10.1183/13993003.02218-2021
The European Respiratory Journal; Godet C, Couturaud F et. al.

Nov 13th, 2021 - In allergic bronchopulmonary aspergillosis (ABPA), prolonged nebulised antifungal treatment may be a strategy for maintaining remission. We performed a randomised, single-blind, clinical trial in 30 centres. Patients with controlled ABPA after a 4...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  8 results

Six Months Versus 12 Months of Oral Itraconazole Therapy for Management of Treatment naïve Subjects With CPA
https://clinicaltrials.gov/ct2/show/NCT03920527

Oct 12th, 2021 - Aspergillus is a saprophytic fungus which is present normally in our surroundings and causes a large number of pulmonary diseases spreading through inhalational route. The spectrum of disease caused by aspergillus spp. is wide with the manifestati...

Study in Adult Asthmatic Patients With Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT03960606

Aug 27th, 2021 - This is a randomized, double-blind, multicenter, placebo controlled, multiple-arm study. Following screening and confirmation of eligibility, subjects will be randomly assigned (1:1:1:1) into 4 arms of 16 subjects each and will receive 10 mg, 20 m...

A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
https://clinicaltrials.gov/ct2/show/NCT04966234

Jul 19th, 2021 - Cystic fibrosis (CF) is the most common inherited life-limiting disease in North European people affecting 90,000 people worldwide with about 45,000 registered in the Patient Registry of the European Cystic Fibrosis Society (ECFS). Progressive lun...

Characterizing Asthma Sputum Elasticity in the UCSF Severe Asthma Research Program
https://clinicaltrials.gov/ct2/show/NCT02103348

Jun 3rd, 2021 - Asthma is a heterogeneous disease characterized by airway hyperreactivity and chronic airway inflammation. Published literature from the last few years has shown that asthma does not behave like a single disease but is more of a syndrome with vast...

Cytokine Profile of Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT03643185

Mar 23rd, 2021 - The study would record patients' medical data at baseline and follow them up for different period of time. Updated data would be recorded and blood( or BALF) of the patients would be drawn for tests or stored as whole blood or serum at -80℃ when p...

see more →

News  3 results

Five Things You Need to Know About Bronchiectasis
https://www.medscape.com/viewarticle/955069

Jul 22nd, 2021 - Bronchiectasis is a chronic condition characterised by symptoms of persistent or recurrent bronchial sepsis caused by irreversible damage to and dilation of the bronchi.[1] The key principles of the diagnosis and management of bronchiectasis were ...

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Eosinophilic Asthma: Reducing Exacerbations and Steroid Use
https://www.medscape.com/viewarticle/838306

Jan 28th, 2015 - This is Andy Shorr from Washington, DC, with the pulmonary literature update. Today I want to highlight a recent article in the New England Journal of Medicine by Ortega and colleagues,[1] who reported the MENSA trial. This study focused on the us...

see more →

Patient Education  2 results see all →